| Early role of vascular dysregulation on late-onset Alzheimer’s disease based on multifactorial data-driven analysis Y Iturria-Medina, RC Sotero, PJ Toussaint, JM Mateos-Pérez, AC Evans Nature communications 7 (1), 11934, 2016 | 993 | 2016 |
| A controlled trial of tacrine in Alzheimer's disease M Farlow, SI Gracon, LA Hershey, KW Lewis, CH Sadowsky, ... Jama 268 (18), 2523-2529, 1992 | 791 | 1992 |
| Clinical efficacy and safety of achieving very low LDL-cholesterol concentrations with the PCSK9 inhibitor evolocumab: a prespecified secondary analysis of the FOURIER trial RP Giugliano, TR Pedersen, JG Park, GM De Ferrari, ZA Gaciong, ... The Lancet 390 (10106), 1962-1971, 2017 | 656 | 2017 |
| Cognitive function in a randomized trial of evolocumab RP Giugliano, F Mach, K Zavitz, C Kurtz, K Im, E Kanevsky, J Schneider, ... New England Journal of Medicine 377 (7), 633-643, 2017 | 501 | 2017 |
| Plasma tau in Alzheimer disease N Mattsson, H Zetterberg, S Janelidze, PS Insel, U Andreasson, ... Neurology 87 (17), 1827-1835, 2016 | 468 | 2016 |
| Memantine treatment in mild to moderate Alzheimer disease: a 24-week randomized, controlled trial ER Peskind, SG Potkin, N Pomara, BR Ott, SM Graham, JT Olin, ... The American Journal of Geriatric Psychiatry 14 (8), 704-715, 2006 | 436 | 2006 |
| In vivo staging of regional amyloid deposition MJ Grothe, H Barthel, J Sepulcre, M Dyrba, O Sabri, SJ Teipel, ... Neurology 89 (20), 2031-2038, 2017 | 380 | 2017 |
| Detailed comparison of amyloid PET and CSF biomarkers for identifying early Alzheimer disease S Palmqvist, H Zetterberg, N Mattsson, P Johansson, ... Neurology 85 (14), 1240-1249, 2015 | 332 | 2015 |
| Patient versus informant perspectives of quality of life in mild cognitive impairment and Alzheimer's disease RE Ready, BR Ott, J Grace International journal of geriatric psychiatry 19 (3), 256-265, 2004 | 328 | 2004 |
| Progress toward standardized diagnosis of vascular cognitive impairment: Guidelines from the Vascular Impairment of Cognition Classification Consensus Study OA Skrobot, SE Black, C Chen, C DeCarli, T Erkinjuntti, GA Ford, ... Alzheimer's & Dementia 14 (3), 280-292, 2018 | 317 | 2018 |
| Quality of life measures for dementia RE Ready, BR Ott Health and quality of life outcomes 1, 1-9, 2003 | 306 | 2003 |
| A commonly carried allele of the obesity-related FTO gene is associated with reduced brain volume in the healthy elderly AJ Ho, JL Stein, X Hua, S Lee, DP Hibar, AD Leow, ID Dinov, AW Toga, ... Proceedings of the National Academy of Sciences 107 (18), 8404-8409, 2010 | 293 | 2010 |
| Acute quadriplegic myopathy: a complication of treatment with steroids, nondepolarizing blocking agents, or both M Hirano, BR Ott, EC Raps, C Minetti, L Lennihan, NP Libbey, E Bonilla, ... Neurology 42 (11), 2082-2082, 1992 | 291 | 1992 |
| Ferritin levels in the cerebrospinal fluid predict Alzheimer’s disease outcomes and are regulated by APOE S Ayton, NG Faux, AI Bush Nature communications 6 (1), 6760, 2015 | 290 | 2015 |
| Impaired awareness of deficits in Alzheimer disease BR Ott, G Lafleche, WM Whelihan, GW Buongiorno, MS Albert, BS Fogel Alzheimer Disease & Associated Disorders 10 (2), 68-76, 1996 | 283 | 1996 |
| Basal forebrain degeneration precedes and predicts the cortical spread of Alzheimer’s pathology TW Schmitz, R Nathan Spreng Nature communications 7 (1), 13249, 2016 | 281 | 2016 |
| Apolipoprotein E (APOE) genotype has dissociable effects on memory and attentional–executive network function in Alzheimer’s disease DA Wolk, BC Dickerson, Alzheimer’s Disease Neuroimaging Initiative, ... Proceedings of the National Academy of Sciences 107 (22), 10256-10261, 2010 | 274 | 2010 |
| Do statins impair cognition? A systematic review and meta-analysis of randomized controlled trials BR Ott, LA Daiello, IJ Dahabreh, BA Springate, K Bixby, M Murali, ... Journal of general internal medicine 30, 348-358, 2015 | 249 | 2015 |
| Subregional neuroanatomical change as a biomarker for Alzheimer's disease D Holland, JB Brewer, DJ Hagler, C Fennema-Notestine, AM Dale, ... Proceedings of the National Academy of Sciences 106 (49), 20954-20959, 2009 | 244 | 2009 |
| A longitudinal study of drivers with Alzheimer disease BR Ott, WC Heindel, GD Papandonatos, EK Festa, JD Davis, LA Daiello, ... Neurology 70 (14), 1171-1178, 2008 | 242 | 2008 |
